Inserm
Inserm (French: Institut national de la santé et de la recherche médicale) is the French National Institute of Health and Medical Research. It is a public scientific and technological institute which operates under the joint authority of the French Ministry of Health and French Ministry of Research.
History[edit]
Inserm was created in 1964 as a successor to the French National Institute of Health. It was established to provide a more focused approach to health and medical research in France, and to ensure that the country remained competitive in these fields on an international level.
Mission[edit]
The mission of Inserm is to promote and develop medical research in France. This includes basic research, clinical research, and public health research. The institute also aims to facilitate the transfer of research findings into healthcare practice and policy, and to provide scientific expertise to support decision making in health policy.
Structure[edit]
Inserm is organized into thematic institutes, each focusing on a specific area of health and medical research. These institutes are spread across France, and each one is associated with a university or other research institution. The institutes work together to coordinate research efforts and to share resources and expertise.
Research[edit]
Inserm conducts research in a wide range of areas, including biology, genetics, neuroscience, oncology, public health, and epidemiology. The institute's research is often multidisciplinary, involving collaborations with other research institutions and with industry.
Impact[edit]
Inserm's research has led to significant advances in many areas of health and medicine. The institute's work has contributed to the development of new treatments and therapies, and to improvements in public health policy and practice.
See also[edit]
References[edit]
External links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
